Form 4: Myriad Genetics Director Colleen F. Reitan Sells Shares Under 10b5-1 Plan

Director Colleen F. Reitan sold 4,6012 shares of Myriad Genetics Inc. common stock at a weighted average price of $27.946 per share on September 3, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Summary

• On September 3, 2024, Colleen F. Reitan, a director of Myriad Genetics Inc., sold 4,6012 shares of common stock.
• The sale was executed under a Rule 10b5-1 trading plan.
• The weighted average price of the shares sold was $27.946.
• The shares were sold in multiple transactions with prices ranging from $27.45 to $28.47.
• Following the transaction, Reitan directly owns 42,533 shares of Myriad Genetics Inc.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing a stock sale by a company director. It doesn't inherently convey positive or negative sentiment, as it's a factual report of a transaction.

Industry Context

This Form 4 filing is a routine disclosure of insider trading activity. It provides transparency into the transactions of company insiders, allowing investors to monitor potential alignment or misalignment of interests between management and shareholders.

Key Dates